A CXCR4 partial agonist improves immunotherapy by targeting immunosuppressive neutrophils and cancer-driven granulopoiesis

Authors:

Abstract
No abstract available
Funding Information
  • National Cancer Institute (R01CA272901)
  • National Cancer Institute (R35CA210088)
  • National Cancer Institute (P30CA013696)
  • Columbia University (P30DK132710)
  • DeGregorio Family Foundation (T32DK007647)
  • National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007647)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK132710)
  • U.S. Department of War (W81XWH-21-10901)
  • National Institutes of Health
  • National Center for Advancing Translational Sciences (UL1TR001873)

This publication has 98 references indexed in Scilit: